在肺部恶化后预测肺功能恢复使用囊性纤维化呼吸道症状日记-慢性呼吸道感染症状尺度
Eliana R Gill1, Christopher H Goss2,3,4, Scott D Sagel5
1Division of Biobehavioral Nursing and Health Informatics, Department of Nursing, University of Washington, Seattle, WA, USA. ergill@uw.edu.
BMC pulmonary medicine
|July 25, 2024
概括
在患有囊性纤维化 (PwCF) 的人群中,在肺部恶化 (PEx) 开始时,高症状负担预示着更慢地恢复到基线肺功能. 监测慢性呼吸道感染症状尺度 (CRISS) 可以识别PwCF的风险.
科学领域:
- 肺部医学 肺部医学
- 临床研究 临床研究
- 患者监测 患者监测
背景情况:
- 囊性纤维化 (PwCF) 患者的肺恶化 (PExs) 会导致显著的医疗费用和肺功能下降.
- 通过慢性呼吸道感染症状量表 (CRISS) 评估的症状负担,可以预测PEx期间的结果.
研究的目的:
- 为了确定PEx发作时症状负担的严重程度是否预测无法恢复到基线肺功能.
- 调查CRISS在PEx期间监控PwCF的实用性.
主要方法:
- 一项纵向观察性研究的二次分析 (N=56).
- 在基线收集的数据,PEx诊断 (访问1),PEx期间 (访问2) 和住院后 (访问3) 的数据.
- 线性回归分析用于评估CRISS得分与肺功能恢复之间的关系.
主要成果:
- 每增加一个点的CRISS得分预测肺功能恢复的0.2点下降.
- 一个CRISS得分>48.3与14%更高的风险不恢复到基线肺功能访问2.
结论:
- 监测CRISS分数是一种高效,可靠,非侵入性的方法,可以在PEx期间评估PwCF状态.
- 症状负担评估对于在PwCF中管理PEx和预测肺功能恢复是有价值的.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Pulmonary Function Tests
315
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
315
Cystic Fibrosis: Management
154
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
154
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Cystic Fibrosis: Pathogenesis
202
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
202
COPD: Management Using Bronchodilators and Corticosteroids
193
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
193


